We, therefore, estimated the risks of all-cause and cardiovascular mortality in different levels of anemia and CKD staging with adjustment of medications, comorbidities, and various laboratory results including eGFR and Hb. The gene discussed is GSTM1; the disease is anemia (phenotype).